Correlation Between Alcon AG and Haemonetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alcon AG and Haemonetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alcon AG and Haemonetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alcon AG and Haemonetics, you can compare the effects of market volatilities on Alcon AG and Haemonetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alcon AG with a short position of Haemonetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alcon AG and Haemonetics.

Diversification Opportunities for Alcon AG and Haemonetics

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Alcon and Haemonetics is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Alcon AG and Haemonetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Haemonetics and Alcon AG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alcon AG are associated (or correlated) with Haemonetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Haemonetics has no effect on the direction of Alcon AG i.e., Alcon AG and Haemonetics go up and down completely randomly.

Pair Corralation between Alcon AG and Haemonetics

Considering the 90-day investment horizon Alcon AG is expected to generate 0.66 times more return on investment than Haemonetics. However, Alcon AG is 1.51 times less risky than Haemonetics. It trades about 0.1 of its potential returns per unit of risk. Haemonetics is currently generating about -0.13 per unit of risk. If you would invest  8,406  in Alcon AG on January 3, 2025 and sell it today you would earn a total of  853.00  from holding Alcon AG or generate 10.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Alcon AG  vs.  Haemonetics

 Performance 
       Timeline  
Alcon AG 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Alcon AG are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak essential indicators, Alcon AG may actually be approaching a critical reversion point that can send shares even higher in May 2025.
Haemonetics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Haemonetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in May 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Alcon AG and Haemonetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alcon AG and Haemonetics

The main advantage of trading using opposite Alcon AG and Haemonetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alcon AG position performs unexpectedly, Haemonetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Haemonetics will offset losses from the drop in Haemonetics' long position.
The idea behind Alcon AG and Haemonetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios